These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 26774630)

  • 1. The use of trimethoprim and sulfamethoxazole (TMP-SMX) in dermatology.
    Michałek K; Lechowicz M; Pastuszczak M; Wojas-Pelc A
    Folia Med Cracov; 2015; 55(1):35-41. PubMed ID: 26774630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose of trimethoprim-sulfamethoxazole to treat skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus.
    Cadena J; Nair S; Henao-Martinez AF; Jorgensen JH; Patterson JE; Sreeramoju PV
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5430-2. PubMed ID: 21930870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.
    Grim SA; Rapp RP; Martin CA; Evans ME
    Pharmacotherapy; 2005 Feb; 25(2):253-64. PubMed ID: 15767239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TMP/SMX is still the preferred empiric antibiotic for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in the HIV population.
    Simoncini GM; Khanlou H
    J Acquir Immune Defic Syndr; 2012 Apr; 59(4):e78. PubMed ID: 22407303
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
    Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
    Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient.
    Bell TL; Foster JN; Townsend ML
    Pharmacotherapy; 2010 May; 30(5):539. PubMed ID: 20412003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillin-resistant Staphylococcus aureus.
    Phillips S; MacDougall C; Holdford DA
    Ann Pharmacother; 2007 Jan; 41(1):13-20. PubMed ID: 17200425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Is the Evidence for Co-trimoxazole, Clindamycin, Doxycycline, and Minocycline in the Treatment of Methicillin-Resistant
    Hong J; Ensom MHH; Lau TTY
    Ann Pharmacother; 2019 Nov; 53(11):1153-1161. PubMed ID: 31177803
    [No Abstract]   [Full Text] [Related]  

  • 9. Minocycline, often forgotten but preferred to trimethoprim-sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections.
    Cunha BA
    Int J Antimicrob Agents; 2013 Dec; 42(6):497-9. PubMed ID: 24126085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and therapeutic evaluation of community-acquired methicillin-resistant Staphylococcus Aureus (MRSA) skin and soft tissue infections in the emergency department.
    Walraven CJ; Lingenfelter E; Rollo J; Madsen T; Alexander DP
    J Emerg Med; 2012 Apr; 42(4):392-9. PubMed ID: 21524884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral trimethoprim/sulfamethoxazole in the treatment of acne vulgaris.
    Bhambri S; Del Rosso JQ; Desai A
    Cutis; 2007 Jun; 79(6):430-4. PubMed ID: 17713145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis.
    de Górgolas M; Avilés P; Verdejo C; Fernández Guerrero ML
    Antimicrob Agents Chemother; 1995 Apr; 39(4):953-7. PubMed ID: 7786002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections.
    Adra M; Lawrence KR
    Ann Pharmacother; 2004 Feb; 38(2):338-41. PubMed ID: 14742775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the combination of daptomycin and trimethoprim-sulfamethoxazole on clinical outcomes in methicillin-resistant Staphylococcus aureus infections.
    Claeys KC; Smith JR; Casapao AM; Mynatt RP; Avery L; Shroff A; Yamamura D; Davis SL; Rybak MJ
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1969-76. PubMed ID: 25605354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children.
    Autmizguine J; Melloni C; Hornik CP; Dallefeld S; Harper B; Yogev R; Sullivan JE; Atz AM; Al-Uzri A; Mendley S; Poindexter B; Mitchell J; Lewandowski A; Delmore P; Cohen-Wolkowiez M; Gonzalez D;
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
    Wordell CJ; Hauptman SP
    Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of adverse drug reactions between high- and standard-dose trimethoprim-sulfamethoxazole in the ambulatory setting.
    Nguyen AT; Gentry CA; Furrh RZ
    Curr Drug Saf; 2013 Apr; 8(2):114-9. PubMed ID: 23713542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
    Fisher RG; Nageswaran S; Valentine ME; McKinney RE
    AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethoprim-sulfamethoxazole therapy for children with acute osteomyelitis.
    Messina AF; Namtu K; Guild M; Dumois JA; Berman DM
    Pediatr Infect Dis J; 2011 Dec; 30(12):1019-21. PubMed ID: 21817950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Has the emergence of community-associated methicillin-resistant Staphylococcus aureus increased trimethoprim-sulfamethoxazole use and resistance?: a 10-year time series analysis.
    Wood JB; Smith DB; Baker EH; Brecher SM; Gupta K
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5655-60. PubMed ID: 22908161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.